JNJ-78934804 not checked

Johnson & Johnson (Janssen) · JNJ-4804

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
4 active
4 in total · 4 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“JNJ-78934804 will be administered subcutaneously as per defined regimen.”In the company’s words, NCT05242484 on ClinicalTrials.gov
Tested for
Colitis, Ulcerative (2 trials), Crohn Disease, Crohn's Disease
Main trialPhase 3
“The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn's disease (a long-term, progressive \[worsens with time\] and life-threatening disease of the intestine).”In the company’s words, NCT07577843 on ClinicalTrials.gov
Other names
JNJ-4804

Other drugs for Colitis, Ulcerative

All 79 drugs for Colitis, Ulcerative

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 12 Jun 2028 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Phase 3Recruiting 11 Aug 2028 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2Active, not recruiting 15 May 2025 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2Active, not recruiting 23 May 2025 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow JNJ-78934804

Following is part of Solo: you see every change to JNJ-78934804 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in